Purpose To develop guideline recommendations for the use of anticoagulation in the
prevention and treatment of venous thromboembolism (VTE) in patients with cancer …

Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic
surgery - Felder, S - 2019 | Cochrane Library Skip to Content Cookies Our site uses cookies to …

Background Patients with acute medical illnesses are at prolonged risk for venous
thrombosis. However, the appropriate duration of thromboprophylaxis remains unknown …

An individualized approach to identify acutely ill medical patients at increased risk of venous
thromboembolism (VTE) and a low risk of bleeding to optimize the benefit and risk of …

Risk of venous thromboembolism (VTE) is elevated in cancer, but individual risk factors
cannot identify a sufficiently high-risk group of outpatients for thromboprophylaxis. We …

Venous thromboembolism (VTE) is often asymptomatic, misdiagnosed, and unrecognized at
death, and there is a lack of routine postmortem examinations. These factors are thought to …

This chapter about treatment for venous thromboembolic disease is part of the American
College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) …

Background Controversy persists regarding the extent of shared pathways between arterial
and venous thrombosis and whether treatments of known efficacy for one disease process …

Background: Extended-duration low-molecular-weight heparin has been shown to prevent
venous thromboembolism (VTE) in high-risk surgical patients. Objective: To evaluate the …

Venous thromboembolism (VTE) is a preventable cause of postoperative morbidity and
mortality; however, audits suggest that the use of thromboprophylaxis is underused. In this …